CDC official overseeing COVID hospitalization data resigns
Digest more
Top News
Reactions and opinions
A new COVID-19 variant spreading across the United States may cause an extremely painful sore throat—dubbed the "razor throat"—among its symptoms. The new "Nimbus" strain, also known as COVID-19 NB 1.
The newest concerning variant of covid-19 is rapidly advancing across the U.S. Data from the Centers for Disease Control and Prevention shows that NB.1.8.1 has started to supplant other circulating strains of the coronavirus.
The NB.1.8.1 COVID-19 variant was linked to a large surge of hospitalizations in parts of Asia earlier this year.
The COVID-19 subvariant "Nimbus" is known for its ultra-contagious and painful sore throat, described as "razor blade throat."
47m
Health and Me on MSNNew Covid-19 Vaccine Policies Are Already Blocking People From Getting Shots—Who Is At Real Risk?Recent changes in U.S. Covid-19 vaccine policy have led to confusion and denial of shots for pregnant women, despite medical evidence supporting vaccination to reduce pregnancy complications and infant risks.
Explore more
1d
Nordot on MSNEpidemiologist fired from Harvard after refusing COVID shot named to CDC vaccine panelWorld-renowned infectious-disease epidemiologist Martin Kulldorff — who was fired from Harvard Medical School last year after refusing the COVID vaccine — just got a new gig. Kulldorff has been named a member of the Centers for Disease Control and Prevention’s Advisory Committee for Immunization Practices.
NEW YORK (AP) — All 17 experts recently dismissed from a government vaccine advisory panel published an essay Monday decrying “destabilizing decisions” made by U.S. Health Secretary Robert F. Kennedy Jr. that could lead to more preventable disease spread.
While COVID-19 transmission remains low in the US, health experts are anxious about the potential for a big summer wave as two factors seem set for a collision course: a lull in infection activity that suggests protective responses have likely waned in the population, and a new SARS-CoV-2 variant with an infectious advantage over other variants.